Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Am Coll Surg. 2010 Sep 15;211(5):601–608. doi: 10.1016/j.jamcollsurg.2010.07.006

Table 3.

Volume, Individual Quality Measures, and Outcomes of Major Cancer Surgery

Value Mortality, adjusted Odds Ratio (95% CI) Readmission, adjusted Odds Ratio (95% CI) Length of stay, adjusted % difference (95% CI) Costs, adjusted % difference (95% CI)
Hospital annual volume
      1st quartile 1.43 (0.91, 2.32) 1.18 (0.92, 1.52) −3.40 (−9.83, 3.48) −11 (−20, 0.1)
      2nd quartile 1.18 (0.76, 1.82) 1.01 (0.81, 1.27) −0.69 (−7.70, 6.85) −3 (−14, 9)
      3rd quartile 1.09 (0.72, 1.66) 1.15 (0.96, 1.39) −0.86 (−8.24, 7.11) −6 (−17, 7)
      4th quartile Referent Referent Referent Referent
Physician annual volume
      1st quartile 1.32 (0.92, 1.89) 0.99 (0.81, 1.22) 12.19 (7.46, 17.13) −1 (−5, 3)
      2nd quartile 1.25 (0.87, 1.81) 0.97 (0.82, 1.15) 9.92 (5.13, 14.92) 3 (−1, 7)
      3rd quartile 1.06 (0.76, 1.48) 0.93 (0.77, 1.12) 3.52 (−1.25, 8.53) −1 (−5, 3)
      4th quartile Referent Referent Referent Referent
Missed quality measures
      No beta blockers first 2 days 0.56 (0.39, 0.79) 1.04 (0.87, 1.24) −10.53 (−13.03, −7.96) −11 (−13, −9)
      No prophylactic antibiotics on day of surgery 1.18 (0.78, 1.78) 1.05 (0.84, 1.32) 0.12 (−3.19, 3.55) −1 (−3, 2)
      Antibiotics received after first postoperative day 1.05 (0.79, 1.39) 1.08 (0.96, 1.21) 21.54 (19.49, 23.61) 17 (16, 19)
      No VTEP first 2 days 0.81 (0.62, 1.06) 0.88 (0.77, 1.00) −1.20 (−3.20, 0.84) −3 (−4, −1)